Issue 5, 2025

Tamarindus indica sub-products as potential tools for simultaneous management of diabetes and obesity

Abstract

Aiming at valorizing industrial wastes of tamarind, the present work evaluated the actions of seed, leaf and peel extracts on starch and fat absorption through starch and triglyceride tolerance tests in mice. The actions of all extracts on the α-amylase and lipase were also characterized using classical kinetic assays. All extracts inhibited starch digestion in vivo, but the seed extract was the most effective one with an ID50 of 151.4 mg kg−1. The mechanism behind this inhibition probably involves the pancreatic α-amylase, which was strongly inhibited by the seed extract under in vitro conditions (IC50 = 13.3 μg mL−1) and much less strongly by the leaf and peel extracts (IC50 values in the vicinity of 400 μg mL−1). The pancreatic lipase, conversely, was inhibited solely by the seed extract, with an IC50 of 31.5 μg mL−1. As a consequence of this property, the seed extract also inhibited triglyceride absorption, as indicated by olive oil tolerance tests, which revealed an ID50 of 214.9 mg kg−1. The seed extract also possessed the strongest antioxidant capacity and the highest content in phenolic groups. Chemical analyses revealed that all extracts present a great variety of phenolic compounds and that the seed extract possesses at least 5 unique compounds (ursodiol, masoprocol, lenticin, chenodeoxycolic acid and 13-keto-9Z,11E-octadecadienoic acid), which, according to docking studies, could be involved in the inhibition of both α-amylase and lipase. The overall conclusion is that the tamarind seed extract displays great potential for being used in the management of obesity and diabetes.

Graphical abstract: Tamarindus indica sub-products as potential tools for simultaneous management of diabetes and obesity

Supplementary files

Article information

Article type
Paper
Submitted
18 Sep 2024
Accepted
13 Jan 2025
First published
17 Feb 2025

Food Funct., 2025,16, 1969-1991

Tamarindus indica sub-products as potential tools for simultaneous management of diabetes and obesity

G. H. Souza, B. Paes Silva, G. A. V. Neto, T. C. Finimundy, T. F. D. Santos, P. S. A. Bueno, F. D. O. Souza, E. J. Pilau, L. Barros, J. F. Comar, L. Bracht, R. M. Peralta, A. Bracht and A. B. Sá-Nakanishi, Food Funct., 2025, 16, 1969 DOI: 10.1039/D4FO04536J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements